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Results: The mean GTV volumes ranged from 149.44 to 
526.53 cc. VMAT plans show good results in comparison with 
3DCRT in both conformity index (0.81±0.09 Vs 0.68±0.07 
respectively, p-value of 0.009), and heterogeneity index 
(0.11±0.03 Vs 0.14±0.02, p value= 0.042). Furthermore, 
minimum doses to PTV in VMAT plans are higher than 3DCRT 
plans (57±1.22 Vs 55.1±0.86, p value= 0.001).  
In risk structures, the lung volume receiving 10Gy, 20Gy and 
30Gy were reduced in VMAT plans (with relative reduction of 
2.27%, p=0.002; 4.87%, p=0.001; 11.8% respectively). Mean 
lung dose was also reduced ( 15 Vs 17.69 ) but not 
statistically significant. V30 of the heart was reduced 
compared to 3DCRT (7.53±6.2 10.43±6.8 with p value of 
0.051). The maximum dose of esophagus with VMAT was 47.7 
Vs 48.69 with 3D CRT ( not statistically significant). 
Moreover, D 50 of the esophagus was less with VMAT ( 19.94 
Vs 23.63) with p value of 0.22. 
Regarding monitor units, the mean values were ( 
461.40±124.42 Vs 227.90±13.52) for VMAT and 3D CRT 
respectively.  
 
Conclusion: Inspite of large PTVs included in our study VMAT 
planes showed tendency toward reduction of mean and high 
lung dose and heart doses. Reduction in esophageal doses 
was not statistically significant , This was obtained without 
impairment of PTV coverage that was improved in some 
cases. VMAT for advanced lung cancer can help to improve 
therapeutic ratio and may open the door for dose escalation 
 
EP-1679  
A single centre experience of using helical tomotherapy 
(HT) for craniospinal irradiation (CSI) 
M. Singhera
1Guy's and St Thomas' NHS Foundation Trust and King's Heath 
Partner's Academic Heath Sciences Centre, Radiotherapy, 
London, United Kingdom 
1, T. Falco1, K. Blythe1, R. Begum1, T. Greener1, 
R. Beaney1, N. Mikhaeel1 
 
Purpose or Objective: CSI is one of the most complex 
radiotherapy (RT) treatments. Conformal 3D RT techniques 
require many fields (field within field / segments) to achieve 
homogeneity and minimise doses to organs at risk (OAR) and 
involve field junctions. The planning process is time 
consuming and the actual treatment delivery is long, 
frequently exceeding 30 minutes. HT offers an excellent 
alternative with the ability to treat patients in supine 
position, without junctions and with better dose distribution. 
The aim of this study is to evaluate the use of HT in CSI with 
emphasis on dosimetric parameters and treatment duration. 
 
Material and Methods: Retrospective analysis of treatment 
planning and dosimetric indices was undertaken on seven 
patients who received cranio-spinal radiotherapy with HT at 
our centre. The HT plan was delivered using 51 beam angles 
per rotation, with a constant modulation factor of 2.0, field 
width of 5 cm and one of two pitches (0.43 or 0.28) to 
optimise treatment plans. An iterative inverse planning 
algorithm based on least squares minimization was used 
which optimises multi-leaf collimator at each beam angle. 
Dose was calculated by convolution and superposition. 
Patients were imaged daily covering different areas of the 
body and corrections applied for directional errors. Data 
analysis was done using descriptive statistics. 
 
Results: Helical tomotherapy plans for seven adult patients 
were analysed. Five patients had a haematological 
malignancy and two had a medulloblastoma. Five patients 
with a haematological diagnosis received a dose of 30Gy in 
1.5Gy/#. Two patients with medulloblastoma received 35 Gy 
delivered in 1.67Gy/#. Details of treatment planning and plan 
evaluation parameters of seven patients are presented in 
Table 1.  
 
 
Overall HT plans achieved excellent PTV coverage with mean 
V95 of 33.5 Gy for medullblastoma patients. The mean V95 
was 28.3 Gy for those with a haematological diagnosis. The 
mean homogeneity index was 1.0. Organs at risk doses were 
well below tolerances required. In particular averaged mean 
heart dose was 10.9±1.3, mean lung dose was 8.6±2.2 and 
mean liver dose was 9.8±1.2. The mean D50% for lung was 7.2 
Gy±3.8 and mean D10% was 20.2Gy±3.6. The mean D50% for 
the heart was 10.1Gy±1.3 and mean D10% was 14.7Gy±2.1. 
 
Conclusion: HT for CSI has many advantages including: the 
ability to treat patients in supine position, no need for 
junctions, excellent PTV coverage, low doses to OAR and 
shorter treatment time. 
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Purpose or Objective: Stereotactic radiosurgery of brain 
metastases requires highly conformal dose distributions. 
Besides beams setup, characteristics of the linear accelerator 
collimator may also play a role. In this study we compared 
the impact of leaf width on the dose outside the target for 
stereotactic radiosurgery of single brain metastases. 
 
Material and Methods: For 10 patients with one lesion, 
treatment plans were generated using two MLC types: Elekta 
Agilty with 0.5cm leaf width and Elekta MLCi2 with 1cm leaf 
width. Two VMAT arcs were used, one coplanar arc and one 
non-coplanar arc (couch 90˚). Five patients had a PTV 
volume ≤ 4 cm³ with a prescription dose of 24Gy in 1 
fraction, and 5 patients had a PTV volume between 4 and 14 
cm³ with a prescription dose of 18Gy in 1 fraction. All plans 
were required to fulfill clinical requirements: 
V100%Dpres>95%VPTV, D0<150%Dpres and OAR doses as low 
as possible and never above clinical constraints. The 
maximum dose in the PTV is kept the same per patient in 
both plans. The quality of the dose distribution outside the 
PTV was evaluated using the mean dose in two ring 
structures, adjacent to the PTV. 
 
Results: The mean dose was evaluated in the first 2 rings of 5 
mm around the PTV(table 1). The difference in mean dose for 
the small lesions(Dpres=24 Gy) of the first ring of 5 mm is 1.8 
Gy in favor of the Agility and 0.9 Gy for the larger 
lesions(Dpres=18 Gy)also in favor of the Agility. The 
difference is smaller for the larger lesions (figure1). Also for 
the second ring of 5 mm, adjacent to the first ring, the 
difference is is 1.1 Gy vs 0.8 Gy also in favor of the Agility.  
 
